Skip to main content
Top
Published in: BMC Pediatrics 1/2015

Open Access 01-12-2015 | Research article

Monitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged < 2 years

Authors: Øystein Rolandsen Riise, Ida Laake, Marianne Adeleide Riise Bergsaker, Hanne Nøkleby, Inger Lise Haugen, Jann Storsæter

Published in: BMC Pediatrics | Issue 1/2015

Login to get access

Abstract

Background

Delayed vaccinations increase the risk for vaccine preventable diseases (VPDs). Monitoring of delayed vaccinations by using a national immunisation registry has not been studied in countries recommending a two-dose (3 and 5 months of age) primary series of e.g., pertussis vaccine. Surveillance/monitoring of all vaccinations may improve vaccination programmes functioning.

Methods

We obtained information from the Norwegian immunisation registry (SYSVAK) on all programme vaccinations received at age up to 730 days in children born in 2010 (n = 63,382). Timely vaccinations were received up to 7 days after the recommended age. Vaccinations were considered delayed if they were received more than one month after the recommended age in the schedule.

Results

In vaccinated children, timely administration of the subsequent three doses of pertussis and one dose of measles occurred in 73.8, 47.6, 53.6 and 43.5 % respectively. Delay for one or more programme vaccinations (diphtheria, tetanus, pertussis, polio, Haemophilus influenza type B, invasive pneumococcal disease, measles, mumps or rubella) was present in 28,336 (44.7 %) children. Among those who were delayed the mean duration was 139 days. The proportion of children that had vaccinations delayed differed among counties (range 37.4 %–57.8 %). Immigrant children were more frequently delayed 52.3 % vs. 43.1 %, RR 1.21 (95 % CI 1.19, 1.24). Children scheduled for vaccines in the summer holiday month (July) were more frequently delayed than others (1st dose pertussis vaccine 6.5 % vs. 3.9 % RR 1.65 (95 % CI 1.48, 1.85). Priming against pertussis (2nd dose), pneumococcal (2nd dose) and measles (1st dose) was delayed in 16.8, 18.6 and 29.3 % respectively.

Conclusion

Vaccinations were frequently delayed. Delayed vaccinations differed among counties and occurred more frequently during the summer vacation (July) and in the immigrant population. Monitoring improves programme surveillance and may be used on an annual basis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med. 2009;360(19):1981–8.CrossRefPubMed Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med. 2009;360(19):1981–8.CrossRefPubMed
2.
go back to reference Lopalco PL, de Carvalho HG, Kreidl P, Leitmeyer K, Giesecke J. Childhood vaccination schedules in Europe vary widely. Is this a problem? Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2009;52(11):1095–8.CrossRefPubMed Lopalco PL, de Carvalho HG, Kreidl P, Leitmeyer K, Giesecke J. Childhood vaccination schedules in Europe vary widely. Is this a problem? Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2009;52(11):1095–8.CrossRefPubMed
4.
go back to reference Vainio K, Ronning K, Steen TW, Arnesen TM, Anestad G, Dudman S. Ongoing outbreak of measles in Oslo, Norway, January-February 2011. Euro surveill. 2011, 16(8). Vainio K, Ronning K, Steen TW, Arnesen TM, Anestad G, Dudman S. Ongoing outbreak of measles in Oslo, Norway, January-February 2011. Euro surveill. 2011, 16(8).
6.
go back to reference Nilsson L, Lepp T, von Segebaden K, Hallander H, Gustafsson L. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance. Vaccine. 2012;30(21):3239–47.CrossRefPubMed Nilsson L, Lepp T, von Segebaden K, Hallander H, Gustafsson L. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance. Vaccine. 2012;30(21):3239–47.CrossRefPubMed
7.
go back to reference Pertussis vaccines. WHO position paper – September 2015. Wkly Epidemiol Rec. 2015;28(35):433–58. Pertussis vaccines. WHO position paper – September 2015. Wkly Epidemiol Rec. 2015;28(35):433–58.
8.
go back to reference Luman ET, Barker LE, Shaw KM, McCauley MM, Buehler JW, Pickering LK. Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed. JAMA. 2005;293(10):1204–11.CrossRefPubMed Luman ET, Barker LE, Shaw KM, McCauley MM, Buehler JW, Pickering LK. Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed. JAMA. 2005;293(10):1204–11.CrossRefPubMed
9.
go back to reference Hull BP, McIntyre PB. Timeliness of childhood immunisation in Australia. Vaccine. 2006;24(20):4403–8.CrossRefPubMed Hull BP, McIntyre PB. Timeliness of childhood immunisation in Australia. Vaccine. 2006;24(20):4403–8.CrossRefPubMed
10.
go back to reference Lernout T, Theeten H, Hens N, Braeckman T, Roelants M, Hoppenbrouwers K, et al. Timeliness of infant vaccination and factors related with delay in Flanders, Belgium. Vaccine. 2014;32(2):284–9.CrossRefPubMed Lernout T, Theeten H, Hens N, Braeckman T, Roelants M, Hoppenbrouwers K, et al. Timeliness of infant vaccination and factors related with delay in Flanders, Belgium. Vaccine. 2014;32(2):284–9.CrossRefPubMed
12.
go back to reference Trogstad L, Ung G, Hagerup-Jenssen M, Cappelen I, Haugen IL, Feiring B. The Norwegian immunisation register--SYSVAK. Euro surveill. 2012, 17(16). Trogstad L, Ung G, Hagerup-Jenssen M, Cappelen I, Haugen IL, Feiring B. The Norwegian immunisation register--SYSVAK. Euro surveill. 2012, 17(16).
15.
go back to reference Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, et al. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013;167(3):274–81.CrossRefPubMed Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, et al. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013;167(3):274–81.CrossRefPubMed
16.
go back to reference Akmatov MK, Mikolajczyk RT. Timeliness of childhood vaccinations in 31 low and middle-income countries. J Epidemiol Community Health. 2012;66(7):e14.CrossRefPubMed Akmatov MK, Mikolajczyk RT. Timeliness of childhood vaccinations in 31 low and middle-income countries. J Epidemiol Community Health. 2012;66(7):e14.CrossRefPubMed
17.
go back to reference Whitney CG, Goldblatt D, O’Brien KL. Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers. Pediatr Infec Dis J. 2014;33 Suppl 2:S172–81.CrossRef Whitney CG, Goldblatt D, O’Brien KL. Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers. Pediatr Infec Dis J. 2014;33 Suppl 2:S172–81.CrossRef
18.
go back to reference Steens A, Bergsaker MA, Aaberge IS, Ronning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine. 2013;31(52):6232–8.CrossRefPubMed Steens A, Bergsaker MA, Aaberge IS, Ronning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine. 2013;31(52):6232–8.CrossRefPubMed
19.
go back to reference Vestrheim DF, Lovoll O, Aaberge IS, Caugant DA, Hoiby EA, Bakke H, et al. Effectiveness of a 2 + 1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine. 2008;26(26):3277–81.CrossRefPubMed Vestrheim DF, Lovoll O, Aaberge IS, Caugant DA, Hoiby EA, Bakke H, et al. Effectiveness of a 2 + 1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine. 2008;26(26):3277–81.CrossRefPubMed
21.
go back to reference Bielicki JA, Achermann R, Berger C. Timing of measles immunization and effective population vaccine coverage. Pediatrics. 2012;130(3):e600–6.CrossRefPubMed Bielicki JA, Achermann R, Berger C. Timing of measles immunization and effective population vaccine coverage. Pediatrics. 2012;130(3):e600–6.CrossRefPubMed
22.
go back to reference Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, et al. Timely Versus Delayed Early Childhood Vaccination and Seizures. Pediatrics. 2014; doi: 10.1542/peds.2013-3429. Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, et al. Timely Versus Delayed Early Childhood Vaccination and Seizures. Pediatrics. 2014; doi: 10.​1542/​peds.​2013-3429.
23.
go back to reference Clark A, Sanderson C. Timing of children’s vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet. 2009;373(9674):1543–9.CrossRefPubMed Clark A, Sanderson C. Timing of children’s vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet. 2009;373(9674):1543–9.CrossRefPubMed
Metadata
Title
Monitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged < 2 years
Authors
Øystein Rolandsen Riise
Ida Laake
Marianne Adeleide Riise Bergsaker
Hanne Nøkleby
Inger Lise Haugen
Jann Storsæter
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2015
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-015-0487-4

Other articles of this Issue 1/2015

BMC Pediatrics 1/2015 Go to the issue